The odds of nonpublication showed a trend towards significance for phase III/IV trials (including trials registered for both phase II and III), and these trials were 3.1 times more likely to be published ( P =.08, OR=3.112, 95% CI: 0.876-11.054); however, the trend did not reach statistical significance.
← all excerpts
Nonpublication Rates and Characteristics of Registered Randomized Clinical Trials in Digital Health: Cross-Sectional Analysis.
1
0.0800
0.0800